Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Narod, SA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 144 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jernstrom, H; Chu, M; Vesprini, D; Tao, YZ; Majeed, N; Deal, C; Pollak, M; Narod, SA
      Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk

      MOLECULAR GENETICS AND METABOLISM
    2. Jernstrom, H; Deal, C; Wilkin, F; Chu, W; Tao, YZ; Majeed, N; Hudson, T; Narod, SA; Pollak, M
      Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    3. Runnebaum, IB; Wang-Gohrke, S; Vesprini, D; Kreienberg, R; Lynch, H; Moslehi, R; Ghadirian, P; Weber, B; Godwin, AK; Risch, H; Garber, J; Lerman, C; Olopade, OI; Foulkes, WD; Karlan, B; Warner, E; Rosen, B; Rebbeck, T; Tonin, P; Dube, MP; Kieback, DG; Narod, SA
      Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

      PHARMACOGENETICS
    4. Pal, T; Liede, A; Mitchell, M; Calender, A; Narod, SA
      Intestinal carcinoid tumours in a father and daughter

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    5. Warner, E; Plewes, DB; Shumak, RS; Catzavelos, GC; Di Prospero, LS; Yaffe, MJ; Goel, V; Ramsay, E; Chart, PL; Cole, DEC; Taylor, GA; Cutrara, M; Samuels, TH; Murphy, JP; Murphy, JM; Narod, SA
      Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    6. Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL
      Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

      LANCET
    7. Narod, SA; Pal, Y; Graham, T; Mitchell, M; Fyles, A
      Tamoxifen and risk of endometrial cancer

      LANCET
    8. Aziz, S; Kuperstein, G; Rosen, B; Cole, D; Nedelcu, R; McLaughlin, J; Narod, SA
      A genetic epidemiological study of carcinoma of the fallopian tube

      GYNECOLOGIC ONCOLOGY
    9. Nam, RK; Toi, A; Vesprini, D; Ho, M; Chu, W; Harvie, S; Sweet, J; Trachtenberg, J; Jewett, MAS; Narod, SA
      V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression

      UROLOGY
    10. Narod, SA; Sun, P; Risch, HA
      Ovarian cancer, oral contraceptives, and BRCA mutations

      NEW ENGLAND JOURNAL OF MEDICINE
    11. Bevan, S; Pal, T; Greenberg, CR; Green, H; Wixey, J; Bignell, G; Narod, SA; Foulkes, WD; Stratton, MR; Houlston, RS
      A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: Confirmation of linkage to TCO1

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    12. Pal, T; Vogl, FD; Chappuis, PO; Tsang, R; Brierley, J; Renard, H; Sanders, K; Kantemiroff, T; Bagha, S; Goldgar, DE; Narod, SA; Foulkes, WD
      Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: A hospital-based study

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    13. Rebbeck, TR; Wang, YT; Kantoff, PW; Krithivas, K; Neuhausen, SL; Godwin, AK; Daly, MB; Narod, SA; Brunet, JS; Vesprini, D; Garber, JE; Lynch, HT; Weber, BL; Brown, M
      Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history

      CANCER RESEARCH
    14. Vesprini, D; Nam, RK; Trachtenberg, J; Jewett, MAS; Tavtigian, SV; Emami, M; Ho, M; Toi, A; Narod, SA
      HPC2 variants and screen-detected prostate cancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    15. Risch, HA; McLaughlin, JR; Cole, DEC; Rosen, B; Bradley, L; Kwan, E; Jack, E; Vesprini, DJ; Kuperstein, G; Abrahamson, JLA; Fan, I; Wong, B; Narod, SA
      Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    16. de los Rios, P; Jack, E; Kuperstein, G; Lynch, H; Lubinski, J; Narod, SA
      Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    17. Manning, AP; Abelovich, D; Ghadirian, P; Lambert, JA; Frappier, D; Provencher, D; Robidoux, A; Peretz, T; Narod, SA; Mes-Masson, AM; Foulkes, WD; Wang, TL; Morgan, K; Fujiwara, TM; Tonin, PN
      Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadianand Yemenite Jewish hereditary breast cancer families

      HUMAN HEREDITY
    18. Jernstrom, H; Vesprini, D; Bradlow, HL; Narod, SA
      Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    19. Narod, SA
      Re: Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    20. Narod, SA; Dube, MP
      Re: Biologic characteristics of interval and screen-detected breast cancers

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    21. Narod, SA
      Clinical characteristics of genetically determined breast cancer

      MANAGEMENT OF PATIENTS AT HIGH RISK FOR BREAST CANCER
    22. Singh, R; Eeles, RA; Durocher, F; Simard, J; Edwards, S; Badzioch, M; Kote-Jarai, Z; Teare, D; Ford, D; Dearnaley, D; Ardern-Jones, A; Murkin, A; Dowe, A; Shearer, R; Kelly, J; Labrie, F; Easton, D; Narod, SA; Tonin, PN; Foulkes, WD
      High risk genes predisposing to prostate cancer development - do they exist?

      PROSTATE CANCER AND PROSTATIC DISEASES
    23. Foulkes, WD; Chappuis, PO; Wong, N; Brunet, JS; Vesprini, D; Rozen, F; Yuan, ZQ; Pollak, MN; Kuperstein, G; Narod, SA; Begin, LR
      Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome

      ANNALS OF ONCOLOGY
    24. Nam, RK; Diamandis, EP; Toi, A; Trachtenberg, J; Magklara, A; Scorilas, A; Papnastasiou, PA; Jewett, MAS; Narod, SA
      Serum human glandular kallikrein-2 protease levels predict the presence ofprostate cancer among men with elevated prostate-specific antigen

      JOURNAL OF CLINICAL ONCOLOGY
    25. Chappuis, PO; Kapusta, L; Begin, LR; Wong, N; Brunet, JS; Narod, SA; Slingerland, J; Foulkes, WD
      Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    26. Pierce, LJ; Strawderman, M; Narod, SA; Oliviotto, I; Eisen, A; Dawson, L; Gaffney, D; Solin, LJ; Nixon, A; Garber, J; Berg, C; Isaacs, C; Heimann, R; Olopade, OI; Haffty, B; Weber, BL
      Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations

      JOURNAL OF CLINICAL ONCOLOGY
    27. Narod, SA; Brunet, JS; Ghadirian, P; Robson, M; Heimdal, K; Neuhausen, SL; Stoppa-Lyonnet, D; Lerman, C; Pasini, B; de los Rios, P; Weber, B; Lynch, H
      Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

      LANCET
    28. Lerman, C; Hughes, C; Croyle, RT; Main, D; Durham, C; Sndyer, C; Bonney, A; Lynch, JF; Narod, SA; Lynch, HT
      Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

      PREVENTIVE MEDICINE
    29. Goshen, R; Chu, W; Elit, L; Pal, T; Hakimi, J; Ackerman, I; Fyles, A; Mitchell, M; Narod, SA
      Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?

      GYNECOLOGIC ONCOLOGY
    30. Nam, RK; Elhaji, Y; Krahn, MD; Hakimi, J; Ho, M; Chu, W; Sweet, J; Trachtenberg, J; Jewett, MAS; Narod, SA
      Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression

      JOURNAL OF UROLOGY
    31. Metcalfe, KA; Liede, A; Hoodfar, E; Scott, A; Foulkes, WD; Narod, SA
      An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

      JOURNAL OF MEDICAL GENETICS
    32. Liede, A; Pal, T; Mitchell, M; Narod, SA
      Delineation of a new syndrome: clustering of pyloric stenosis, endometriosis, and breast cancer in two families

      JOURNAL OF MEDICAL GENETICS
    33. Hamel, N; Karimi, S; Hebert-Blouin, MN; Brunet, JS; Gilfix, B; Ghadirian, P; Black, MJ; Narod, SA; Foulkes, WD
      Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco

      INTERNATIONAL JOURNAL OF CANCER
    34. Kuperstein, G; Foulkes, WD; Ghadirian, P; Hakimi, J; Narod, SA
      A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

      CLINICAL GENETICS
    35. Vassilikos, EJK; Yu, H; Trachtenberg, J; Nam, RK; Narod, SA; Bromberg, IL; Diamandis, EP
      Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up

      CLINICAL BIOCHEMISTRY
    36. Lal, G; Liu, G; Schmocker, B; Kaurah, P; Ozcelik, H; Narod, SA; Redston, M; Gallinger, S
      Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations

      CANCER RESEARCH
    37. Liede, A; Cohen, B; Black, DM; Davidson, RH; Renwick, A; Hoodfar, E; Olopade, OI; Micek, M; Anderson, V; De Mey, R; Fordyce, A; Warner, E; Dann, JL; King, MC; Weber, B; Narod, SA; Steel, CM
      Evidence of a founder BRCA1 mutation in Scotland

      BRITISH JOURNAL OF CANCER
    38. Liu, G; Ghadirian, P; Vesprini, D; Hamel, N; Paradis, AJ; Lai, G; Gallinger, S; Narod, SA; Foulkes, WD
      Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma

      BRITISH JOURNAL OF CANCER
    39. Liede, A; Metcalfe, K; Hanna, D; Hoodfar, E; Snyder, C; Durham, C; Lynch, HT; Narod, SA
      Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling

      AMERICAN JOURNAL OF HUMAN GENETICS
    40. Mazoyer, S; Leary, J; Kirk, J; Fleischmann, E; Wagner, T; Claes, K; Messiaen, L; Foulkes, W; Desrochers, M; Simard, J; Phelan, CM; Kwan, E; Narod, SA; Vahteristo, P; Nevanlinna, H; Durando, X; Bignon, YJ; Peyrat, JP; Bonnardel, C; Sinilnikova, OM; Puget, N; Lenoir, GM; Mazoyer, S; Audoynaud, C; Goldgar, D; Maugard, C; Caux, V; Gad, S; Stoppa-Lyonnet, D; Nogues, C; Lidereau, R; Machavoine, C; Bressac-de Paillerets, B; Kuschel, B; Betz, B; Niederacher, D; Beckmann, MW; Hamann, U; Gayther, SA; Ponder, BAP; Robinson, M; Taylor, GR; Bishop, T; Catteau, A; Solomon, E; Cohen, B; Steel, M; Collins, N; Stratton, M; van der Looij, M; Olah, E; Miller, NJ; Barton, DE; Sverdlov, RS; Friedman, E; Radice, P; Montagna, M; Sensi, E; Caligo, M; van Eijk, R; Devilee, P; van der Luijt, R; Heimdal, K; Moller, P; Borg, A; Diez, O; Cortes, J; Domenech, M; Baiget, M; Osorio, A; Benitez, J; Borg, A; Maillet, P; Sappino, AP; Ozdag, H; Ozcelik, T; Ozturk, M; Rohlfs, EM; Boyd, J; McDermott, D; Offit, K; Unger, M; Nathanson, K; Weber, BL; Sellers, TA; Hampton, E; Couch, FJ; Neuhausen, S
      The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations

      AMERICAN JOURNAL OF HUMAN GENETICS
    41. Gorski, B; Byrski, T; Huzarski, T; Jakubowska, A; Menkiszak, J; Gronwald, J; Pluzanska, A; Bebenek, M; Fischer-Maliszewska, L; Grzybowska, E; Narod, SA; Lubinski, J
      Founder mutations in the BRCA1 gene in polish families with breast-ovariancancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    42. Moslehi, R; Chu, W; Karlan, B; Fishman, D; Risch, H; Fields, A; Smotkin, D; Ben-David, Y; Rosenblatt, J; Russo, D; Schwartz, P; Tung, N; Warner, E; Rosen, B; Friedman, J; Brunet, JS; Narod, SA
      BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    43. Lynch, HT; Watson, P; Tinley, S; Snyder, C; Durham, C; Lynch, J; Kirnarsky, Y; Serova, O; Lenoir, G; Lerman, C; Narod, SA
      An update on DNA-Based BRCA1/BRCA2 genetic counseling in hereditary breastcancer

      CANCER GENETICS AND CYTOGENETICS
    44. Jernstrom, H; Lerman, C; Ghadirian, P; Lynch, HT; Weber, B; Garber, J; Daly, M; Olopade, OI; Foulkes, WD; Warner, E; Brunet, JS; Narod, SA
      Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

      LANCET
    45. Chappuis, PO; Narod, SA; Foulkes, WD
      Screening for ovarian cancer

      LANCET
    46. Narod, SA; Brunet, JS
      Oral contraceptives and hereditary ovarian cancer - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    47. van Orsouw, NJ; Dhanda, RK; Elhaji, Y; Narod, SA; Li, FP; Eng, C; Vijg, J
      A highly accurate, low cost test for BRCA1 mutations

      JOURNAL OF MEDICAL GENETICS
    48. Zweemer, RP; Shaw, PA; Verheijen, RMH; Ryan, A; Berchuck, A; Ponder, BAJ; Risch, H; McLaughlin, JR; Narod, SA; Menko, FH; Kenemans, P; Jacobs, IJ
      Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations

      JOURNAL OF CLINICAL PATHOLOGY
    49. Tonin, PN; Mes-Masson, AM; Narod, SA; Ghadirian, P; Provencher, D
      Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

      CLINICAL GENETICS
    50. Lynch, HT; Watson, P; Narod, SA
      The genetic epidemiology of male breast carcinoma

      CANCER
    51. Wang-Gohrke, S; Weikel, W; Risch, H; Vesprini, D; Abrahamson, J; Lerman, C; Godwin, A; Moslehi, R; Olipade, O; Brunet, JS; Stickeler, E; Kieback, DG; Kreienberg, R; Weber, B; Narod, SA; Runnebaum, IB
      Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

      BRITISH JOURNAL OF CANCER
    52. Foulkes, WD; Brunet, JS; Warner, E; Goodwin, PJ; Meschino, W; Narod, SA; Goss, PE; Glendon, G
      The importance of a family history of breast cancer in predicting the presence of a BRCA mutation

      AMERICAN JOURNAL OF HUMAN GENETICS
    53. Rebbeck, TR; Kantoff, PN; Krithivas, K; Neuhausen, S; Blackwood, MA; Godwin, AK; Daly, MB; Narod, SA; Garber, JE; Lynch, HT; Weber, BL; Brown, M
      Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

      AMERICAN JOURNAL OF HUMAN GENETICS
    54. Rebbeck, TR; Levin, AM; Eisen, A; Snyder, C; Watson, P; Cannon-Albright, L; Isaacs, C; Olopade, O; Garber, JE; Godwin, AK; Daly, MB; Narod, SA; Neuhausen, SL; Lynch, HT; Weber, BL
      Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    55. Boyd, J; Narod, SA
      Association between nonrandom X-chromosome inactivation and BRCA1 mutationin germline DNA of patients with ovarian cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    56. KERR B; FOULKES WD; CADE D; HADFIELD L; HOPWOOD P; SERRUYA C; HOARE E; NAROD SA; EVANS DG
      FALSE FAMILY HISTORY OF BREAST-CANCER IN THE FAMILY CANCER CLINIC

      European journal of surgical oncology
    57. FOULKES WD; WONG N; BRUNET JS; NAROD SA
      BRCA MUTATIONS AND SURVIVAL IN BREAST-CANCER

      Journal of clinical oncology
    58. LIEDE A; TONIN PN; SUN CC; SERRUYA C; DALY MB; NAROD SA; FOULKES WD
      IS HEREDITARY SITE-SPECIFIC OVARIAN-CANCER A DISTINCT GENETIC CONDITION

      American journal of medical genetics
    59. FOULKES WD; WONG N; ROZEN F; BRUNET JS; NAROD SA
      SURVIVAL OF PATIENTS WITH BREAST-CANCER AND BRCA1 MUTATIONS

      Lancet
    60. NAROD SA; RISCH H; MOSLEHI R; DORUM A; NEUHAUSEN S; OLSSON H; PROVENCHER D; RADICE P; EVANS G; BISHOP S; BRUNET JS; PONDER BAJ
      ORAL-CONTRACEPTIVES AND THE RISK OF HEREDITARY OVARIAN-CANCER

      The New England journal of medicine
    61. PAL T; FLANDERS T; MITCHELLLEHMAN M; MACMILLAN A; BRUNET JS; NAROD SA; FOULKES WD
      GENETIC-IMPLICATIONS OF DOUBLE PRIMARY CANCERS OF THE COLORECTUM AND ENDOMETRIUM

      Journal of Medical Genetics
    62. LIEDE A; METCALFE K; OFFIT K; BROWN K; MILLER S; NAROD SA; MOSLEHI R
      A FAMILY WITH 3 GERMLINE MUTATIONS IN BRCA1 AND BRCA2

      Clinical genetics
    63. ABRAHAMSON J; MOSLEHI R; VESPRINI D; KARLAN B; FISHMAN D; SMOTKIN D; BENDAVID Y; BIRAN H; FIELDS A; BRUNET JS; NAROD SA
      NO ASSOCIATION OF THE I1307K APC ALLELE WITH OVARIAN-CANCER RISK IN ASHKENAZI JEWS

      Cancer research
    64. PHELAN CM; LANCASTER JM; GUMBS C; DELOSRIOS P; ABRAHAMSON J; WARNER E; PARFREY NA; FUTREAL PA; NAROD SA
      BRCA1 AND BRCA2 MUTATION SCREENING IN BREAST-CANCER FAMILIES

      British Journal of Cancer
    65. GODARD B; FOULKES WD; PROVENCHER N; BRUNET JS; TONIN PN; MESMASSON AM; NAROD SA; GHADIRIAN P
      RISK-FACTORS FOR FAMILIAL AND SPORADIC OVARIAN-CANCER AMONG FRENCH-CANADIANS - A CASE-CONTROL STUDY

      American journal of obstetrics and gynecology
    66. TONIN PN; MESMASSON AM; FUTREAL PA; MORGAN K; MAHON M; FOULKES WD; COLE DEC; PROVENCHER D; GHADIRIAN P; NAROD SA
      FOUNDER BRCA1 AND BRCA2 MUTATIONS IN FRENCH-CANADIAN BREAST AND OVARIAN-CANCER FAMILIES

      American journal of human genetics
    67. NAROD SA
      HOST SUSCEPTIBILITY TO CANCER PROGRESSION

      American journal of human genetics
    68. NEUHAUSEN SL; GODWIN AK; GERSHONIBARUCH R; SCHUBERT E; GARBER J; STOPPALYONNET D; OLAH E; CSOKAY B; SEROVA O; LALLOO F; OSORIO A; STRATTON M; OFFIT K; BOYD J; CALIGO MA; SCOTT RJ; SCHOFIELD A; TEUGELS E; SCHWAB M; CANNONALBRIGHT L; BISHOP T; EASTON D; BENITEZ J; KING MC; PONDER BAJ; WEBER B; DEVILEE P; BORG A; NAROD SA; GOLDGAR D
      HAPLOTYPE AND PHENOTYPE ANALYSIS OF 9 RECURRENT BRCA2 MUTATIONS IN 111 FAMILIES - RESULTS OF AN INTERNATIONAL STUDY

      American journal of human genetics
    69. LIEDE A; REHAL P; VESPRINI D; JACK E; ABRAHAMSON J; NAROD SA
      A BREAST-CANCER PATIENT OF SCOTTISH DESCENT WITH GERM-LINE MUTATIONS IN BRCA1 AND BRCA2

      American journal of human genetics
    70. EELES RA; DUROCHER F; EDWARDS S; TEARE D; BADZIOCH M; HAMOUDI R; GILL S; BIGGS P; DEARNALEY D; ARDERNJONES A; DOWE A; SHEARER R; MCLENNAN DL; NORMAN RL; GHADIRIAN P; APRIKIAN A; FORD D; AMOS C; KING TM; LABRIE F; SIMARD J; NAROD SA; EASTON D; FOULKES WD; FOULKES WD
      LINKAGE ANALYSIS OF CHROMOSOME 1Q MARKERS IN 136 PROSTATE-CANCER FAMILIES

      American journal of human genetics
    71. BRUNET JS; GHADIRIAN P; REBBECK TR; LERMAN C; GARBER JE; TONIN PN; ABRAHAMSON J; FOULKES WD; DALY M; WAGNERCOSTALAS J; GODWIN A; OLOPADE OI; MOSLEHI R; LIEDE A; FUTREAL PA; WEBER BL; LENOIR GM; LYNCH HT; NAROD SA
      EFFECT OF SMOKING ON BREAST-CANCER IN CARRIERS OF MUTANT BRCA1 OR BRCA2 GENES

      Journal of the National Cancer Institute
    72. FOULKES WD; WONG N; BRUNET JS; BEGIN LR; ZHANG JC; MARTINEZ JJ; ROZEN F; TONIN PN; NAROD SA; KARP SE; POLLAK MN
      GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER

      Clinical cancer research
    73. OZCELIK H; SCHMOCKER B; DINICOLA N; SHI XH; LANGER B; MOORE M; TAYLOR BR; NAROD SA; DARLINGTON G; ANDRULIS IL; GALLINGER S; REDSTON M
      GERMLINE BRCA2 6174DELT MUTATIONS IN ASHKENAZI JEWISH PANCREATIC-CANCER PATIENTS

      Nature genetics
    74. RAHMAN N; ARBOUR L; TONIN P; BARUCHEL S; PRITCHARDJONES K; NAROD SA; STRATTON MR
      THE FAMILIAL WILMS-TUMOR SUSCEPTIBILITY GENE, FWT1, MAY NOT BE A TUMOR-SUPPRESSOR GENE

      Oncogene
    75. MARCUS JN; WATSON P; PAGE DL; NAROD SA; TONIN P; LENOIR GM; SEROVA O; LYNCH HT
      BRCA2 HEREDITARY BREAST-CANCER PATHOPHENOTYPE

      Breast cancer research and treatment
    76. DRUKER HA; KASPRZAK L; BEGIN LR; JOTHY S; NAROD SA; FOULKES WD
      FAMILY WITH GRAVES-DISEASE, MULTINODULAR GOITER, NONMEDULLARY THYROID-CARCINOMA, AND ALVEOLAR RHABDOMYOSARCOMA

      American journal of medical genetics
    77. NAROD SA
      ON BEING THE RIGHT SIZE - A REAPPRAISAL OF MAMMOGRAPHY TRIALS IN CANADA AND SWEDEN

      Lancet
    78. FOULKES WD; NAROD SA
      OVARIAN-CANCER RISK AND FAMILY HISTORY

      Lancet
    79. FOULKES WD; BUU PN; FILIATRAULT D; LECLERC JM; NAROD SA
      EXCESS OF CONGENITAL-ABNORMALITIES IN FRENCH-CANADIAN CHILDREN WITH NEUROBLASTOMA - A CASE SERIES STUDY FROM MONTREAL

      Medical and pediatric oncology
    80. BRUNET JS; NAROD SA; TONIN P; FOULKES WD
      BRCA1 MUTATIONS AND SURVIVAL IN WOMEN WITH OVARIAN-CANCER

      The New England journal of medicine
    81. MARCUS JN; WATSON P; PAGE DL; NAROD SA; TONIN P; SEROVA O; LENOIR GM; LYNCH HT
      BRCA2 AND BRCA1 BREAST-CANCER PHENOTYPES

      Laboratory investigation
    82. SUN S; POLLOCK PM; LIU L; KARIMI S; JOTHY S; MILNER BJ; RENWICK A; LASSAM NJ; HAYWARD NK; HOGG D; NAROD SA; FOULKES WD
      CDKN2A MUTATION IN A NON-FAMMM KINDRED WITH CANCERS AT MULTIPLE SITESRESULTS IN A FUNCTIONALLY ABNORMAL PROTEIN

      International journal of cancer
    83. NAROD SA
      HEREDITARY BREAST-CARCINOMA SYNDROMES

      Cancer
    84. MARCUS JN; PAGE DL; WATSON P; NAROD SA; LENOIR GM; LYNCH HT
      BRCA1 AND BRCA2 HEREDITARY BREAST-CARCINOMA PHENOTYPES

      Cancer
    85. LERMAN C; PETERS JA; ADES T; FINK D; BARR P; BIESECKER BB; BROOKS SW; CALZONE KA; CROYLE RT; FINE BA; GREEN B; LEMON SJ; LYNCH HT; NAROD SA; OFFIT K; PEARLMAN D; TINLEY ST; VARRICCHIO C
      GENETIC-COUNSELING ISSUES - WORKSHOP NO.2

      Cancer
    86. MULCAHY GM; GOGGINS M; WILLIS D; DECKER RA; LUCE MC; PARSONS R; MARKOWITZ S; NAROD SA; HOLT JT; PAGE DL; MAUER AM; THOR A
      PATHOLOGY AND GENETIC TESTING - WORKSHOP NO.6

      Cancer
    87. BIGNELL GR; CANZIAN F; SHAYEGHI M; STARK M; SHUGART YY; BIGGS P; MANGION J; HAMOUDI R; ROSENBLATT J; BUU P; SUN S; STOFFER SS; GOLDGAR DE; ROMEO G; HOULSTON RS; NAROD SA; STRATTON MR; FOULKES WD
      FAMILIAL NONTOXIC MULTINODULAR THYROID GOITER LOCUS MAPS TO CHROMOSOME-149 BUT DOES NOT ACCOUNT FOR FAMILIAL NONMEDULLARY THYROID-CANCER

      American journal of human genetics
    88. REBBECK TR; BLACKWOOD MA; WALKER AH; WHITE DL; GODWIN AK; DALY MB; GARBER JE; WEBER BL; NAROD SA
      ASSOCIATION OF BREAST-CANCER INCIDENCE WITH NAT2 GENOTYPE AND SMOKINGIN BRCA1 MUTATION CARRIERS

      American journal of human genetics
    89. ABRAHAMSON JLA; VESPRINI DJ; MCLAUGHLIN J; COLE D; ROSEN B; BRADLEY L; ROBB K; JACK E; REHAL P; MORRIS A; PATTERSON C; FAN I; BRUNEL JS; NAROD SA; RISCH HA
      HIGH PROPORTION OF GERMLINE BRCA1 AND BRCA2 MUTATIONS IN UNSELECTED OVARIAN-CANCER

      American journal of human genetics
    90. PAL T; FLANDERS T; LEHMAN M; MACMILLAN A; BRUNET JS; NAROD SA; FOULKES WD
      IMPLICATIONS OF DOUBLE PRIMARY CANCERS OF THE COLON AND ENDOMETRIUM

      American journal of human genetics
    91. RAHMAN N; ARBOUR L; TONIN P; SCHWARTZ C; NAROD SA; PRITCHARDJONES K; STRATTON MR
      CHARACTERIZATION OF THE FAMILIAL WILMS-TUMOR GENE FWT1

      American journal of human genetics
    92. WONG N; BRUNET JS; BEGIN LR; ZHANG JC; MARTINEZ JJ; TONIN PN; NAROD SA; KARP SE; POLLAK MN; FOULKES WD
      GERM-LINE BRCA1 MUTATION IS AN ADVERSE PROGNOSTIC FACTOR IN ASHKENAZIJEWISH WOMEN WITH BREAST-CANCER

      American journal of human genetics
    93. BIGNELL GR; CANZIAN F; SHAYEGHI M; STARK M; SHUGART YY; BIGGS P; MANGION J; HAMOUDI R; ROSENBLATT J; BUU P; SUN S; STOFFER SS; GOLDGAR DE; ROMEO G; HOULSTON RS; NAROD SA; STRATTON MR; FOULKES WD
      A FAMILIAL NONTOXIC MULTINODULAR THYROID GOITER LOCUS MAPS TO CHROMOSOME 14Q BUT DOES NOT ACCOUNT FOR FAMILIAL NON-MEDULLARY THYROID-CANCER

      American journal of human genetics
    94. NAROD SA; HAWKINS MM; ROBERTSON CM; STILLER CA
      CONGENITAL-ANOMALIES AND CHILDHOOD-CANCER IN GREAT-BRITAIN

      American journal of human genetics
    95. SEROVA OM; MAZOYER S; PUGET N; DUBOIS V; TONIN P; SHUGART YY; GOLDGAR D; NAROD SA; LYNCH HT; LENOIR GM
      MUTATIONS IN BRCA1 AND BRCA2 IN BREAST-CANCER FAMILIES - ARE THERE MORE BREAST CANCER-SUSCEPTIBILITY GENES

      American journal of human genetics
    96. FOULKES WD; NAROD SA
      FAMILY HISTORY OF CANCER AND RISK OF LUNG-CANCER AMONG LIFETIME NONSMOKING WOMEN IN THE UNITED-STATES

      American journal of epidemiology
    97. TONIN P; WEBER B; OFFIT K; COUCH F; REBBECK TR; NEUHAUSEN S; GODWIN AK; DALY M; WAGNERCOSTALOS J; BERMAN D; GRANA G; FOX E; KANE MF; KOLODNER RD; KRAINER M; HABER DA; STRUEWING JP; WARNER E; ROSEN B; LERMAN C; PESHKIN B; NORTON L; SEROVA O; FOULKES WD; LYNCH HT; LENOIR GM; NAROD SA; GARBER JE
      FREQUENCY OF RECURRENT BRCA1 AND BRCA2 MUTATIONS IN ASHKENAZI JEWISH BREAST-CANCER FAMILIES

      Nature medicine
    98. RAHMAN N; ARBOUR L; TONIN P; RENSHAW J; PELLETIER J; BARUCHEL S; PRITCHARDJONES K; STRATTON MR; NAROD SA
      EVIDENCE FOR A FAMILIAL WILMS-TUMOR GENE (FWT1) ON CHROMOSOME 17Q12-Q21

      Nature genetics
    99. PHELAN CM; LANCASTER JM; TONIN P; GUMBS C; COCHRAN C; CARTER R; GHADIRIAN P; PERRET C; MOSLEHI R; DION F; FAUCHER MC; DOLE K; KARIMI S; FOULKES W; LOUNIS H; WARNER E; GOSS P; ANDERSON D; LARSSON C; NAROD SA; FUTREAL PA
      MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES (VOL 13, PG 120, 1996)

      Nature genetics
    100. PHELAN CM; LANCASTER JM; TONIN P; GUMBS C; COCHRAN C; CARTER R; GHADIRIAN P; PERRET C; MOSLEHI R; DION F; FAUCHER MC; DOLE K; KARIMI S; FOULKES W; LOUNIS H; WARNER E; GOSS P; ANDERSON D; LARSSON C; NAROD SA; FUTREAL PA
      MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES

      Nature genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 16:05:21